Plasma Fractionation Market Size, Trends, Analysis, and Outlook By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hosp

Plasma Fractionation Market Size, Trends, Analysis, and Outlook By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes), by Country, Segment, and Companies, 2024-2032

The global Plasma Fractionation market size is poised to register 6.4% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Plasma Fractionation market across By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes)

The future of the plasma fractionation market is driven by advancements in bioprocessing, increasing demand for plasma-derived therapies, and growing applications in immunotherapy, hematology, and rare diseases. Plasma fractionation is a biomanufacturing process used to separate and purify plasma proteins from human blood plasma to produce therapeutic products such as immunoglobulins, albumin, clotting factors, and alpha-1 antitrypsin for the treatment of various medical conditions, including autoimmune disorders, bleeding disorders, and primary immunodeficiencies. With the rise of biologics, gene therapies, and regenerative medicine, there is a growing need for plasma-derived products that offer purity, safety, and efficacy for patients with chronic and life-threatening diseases. Further, technological innovations such as chromatography, viral inactivation, and nanofiltration are driving the development of next-generation plasma fractionation processes with improved yield, scalability, and viral safety for a wide range of plasma-derived therapies. Over the forecast period to 2030, expanding applications in oncology, neurology, and infectious diseases, coupled with increasing demand for recombinant plasma proteins and gene-edited cell therapies, are expected to drive market growth and innovation, enabling biopharmaceutical companies and plasma fractionators to meet the growing demand for life-saving plasma-derived products and improve patient access to essential therapies.

Plasma Fractionation Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Plasma Fractionation market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Plasma Fractionation survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Plasma Fractionation industry.

Key market trends defining the global Plasma Fractionation demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Plasma Fractionation Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Plasma Fractionation industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Plasma Fractionation companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Plasma Fractionation industry

Leading Plasma Fractionation companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Plasma Fractionation companies.

Plasma Fractionation Market Study- Strategic Analysis Review

The Plasma Fractionation market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Plasma Fractionation Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Plasma Fractionation industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Plasma Fractionation Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Plasma Fractionation Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Plasma Fractionation market segments. Similarly, Strong market demand is encouraging Canadian Plasma Fractionation companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Plasma Fractionation market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Plasma Fractionation Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Plasma Fractionation industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Plasma Fractionation market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Plasma Fractionation Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Plasma Fractionation in Asia Pacific. In particular, China, India, and South East Asian Plasma Fractionation markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Plasma Fractionation Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Plasma Fractionation Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Plasma Fractionation market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Plasma Fractionation.

Plasma Fractionation Market Company Profiles

The global Plasma Fractionation market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ADMA Biologics Inc, Bharat Serums and Vaccines Ltd, Centurion Pharma, China Biologic Products Holdings Inc, CSL Ltd, Emergent BioSolutions Inc, Fusion Healthcare, GC Pharma, Grifols S.A., Hemarus Therapeutics Ltd, Hualan Biological Engineering Inc, Intas Pharmaceuticals Ltd, Japan Blood Products Organization, Kamada Ltd, Kedrion S.p.A., LFB SA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd, Prothya Biosolutions Pvt. Ltd, Sanquin Blood Supply Foundation, Shanghai RAAS Blood Products Co. Ltd, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, SK Plasma Co. Ltd, Takeda Pharmaceutical Company Ltd, Virchow Biotech Private Ltd.

Recent Plasma Fractionation Market Developments

The global Plasma Fractionation market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Plasma Fractionation Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

Immunoglobulins

-Intravenous Immunoglobulins

-Subcutaneous Immunoglobulins

-Others

Coagulation Factor Concentrates

-Factor VIII

-Factor IX

-Von Willebrand Factor

-Others

Albumin

Protease Inhibitors

Others

By Application

Neurology

Immunology

Hematology

Pulmonology

Others

By End-User

Hospitals and Clinics

Clinical Research Laboratories

Academic institutes

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

ADMA Biologics Inc

Bharat Serums and Vaccines Ltd

Centurion Pharma

China Biologic Products Holdings Inc

CSL Ltd

Emergent BioSolutions Inc

Fusion Healthcare

GC Pharma

Grifols S.A.

Hemarus Therapeutics Ltd

Hualan Biological Engineering Inc

Intas Pharmaceuticals Ltd

Japan Blood Products Organization

Kamada Ltd

Kedrion S.p.A.

LFB SA

Octapharma AG

PlasmaGen BioSciences Pvt. Ltd

Prothya Biosolutions Pvt. Ltd

Sanquin Blood Supply Foundation

Shanghai RAAS Blood Products Co. Ltd

Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd

SK Plasma Co. Ltd

Takeda Pharmaceutical Company Ltd

Virchow Biotech Private Ltd

Formats Available: Excel, PDF, and PPT